Tulip Jhaveri, MD, | |
2500 N State St, Jackson, MS 39216-4500 | |
(601) 815-2005 | |
Not Available |
Full Name | Tulip Jhaveri |
---|---|
Gender | Male |
Speciality | Infectious Disease |
Experience | 10 Years |
Location | 2500 N State St, Jackson, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760864557 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 263938 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Mississippi Med Center | Jackson, MS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
State Of Mississippi - University Of Mississippi Medical Center | 1850293036 | 804 |
News Archive
KHN Midwest editor and correspondent Laura Ungar appeared on "CNN Newsroom with Brooke Baldwin" to discuss Vice President Mike Pence's appointment to lead the nation's response to the novel coronavirus in light of how he handled a 2015 HIV outbreak when he was governor of Indiana.
The Atlantic Cities profiles the work of Dirk Brockmann, a theoretical physicist and professor of complex systems at Northwestern University, and other researchers who are examining how modern transportation, such as air travel, affect the spread of disease globally.
Serological antibody immunoassays are one of the essential tools to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In a new study, Immunoglobulin G (IgG) antibodies are detected in a large cohort, lasting up to 140 days. The researchers propose an alternative to reverse transcription-polymerase chain reaction (RT-PCR) positive status as a standard for assessing SARS-CoV-2 antibody assays and show robust performance metrics for the AbC-19 rapid test.
Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use point-of-care diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed an agreement with Portola Pharmaceuticals, Inc. to develop and supply the VerifyNow System and VerifyNowTests for use in clinical trials.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces that patient screening has begun in the second of two Phase 3 clinical trials with the investigational topical drug candidate DSC127 for the treatment of diabetic foot ulcers.
› Verified 9 days ago
Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
KHN Midwest editor and correspondent Laura Ungar appeared on "CNN Newsroom with Brooke Baldwin" to discuss Vice President Mike Pence's appointment to lead the nation's response to the novel coronavirus in light of how he handled a 2015 HIV outbreak when he was governor of Indiana.
The Atlantic Cities profiles the work of Dirk Brockmann, a theoretical physicist and professor of complex systems at Northwestern University, and other researchers who are examining how modern transportation, such as air travel, affect the spread of disease globally.
Serological antibody immunoassays are one of the essential tools to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In a new study, Immunoglobulin G (IgG) antibodies are detected in a large cohort, lasting up to 140 days. The researchers propose an alternative to reverse transcription-polymerase chain reaction (RT-PCR) positive status as a standard for assessing SARS-CoV-2 antibody assays and show robust performance metrics for the AbC-19 rapid test.
Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use point-of-care diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed an agreement with Portola Pharmaceuticals, Inc. to develop and supply the VerifyNow System and VerifyNowTests for use in clinical trials.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces that patient screening has begun in the second of two Phase 3 clinical trials with the investigational topical drug candidate DSC127 for the treatment of diabetic foot ulcers.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Tulip Jhaveri, MD, 504 Clinton Center Drive, Cbo - Suite 4300, Clinton, MS 39056-5610 Ph: (601) 815-2005 | Tulip Jhaveri, MD, 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 815-2005 |
News Archive
KHN Midwest editor and correspondent Laura Ungar appeared on "CNN Newsroom with Brooke Baldwin" to discuss Vice President Mike Pence's appointment to lead the nation's response to the novel coronavirus in light of how he handled a 2015 HIV outbreak when he was governor of Indiana.
The Atlantic Cities profiles the work of Dirk Brockmann, a theoretical physicist and professor of complex systems at Northwestern University, and other researchers who are examining how modern transportation, such as air travel, affect the spread of disease globally.
Serological antibody immunoassays are one of the essential tools to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In a new study, Immunoglobulin G (IgG) antibodies are detected in a large cohort, lasting up to 140 days. The researchers propose an alternative to reverse transcription-polymerase chain reaction (RT-PCR) positive status as a standard for assessing SARS-CoV-2 antibody assays and show robust performance metrics for the AbC-19 rapid test.
Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use point-of-care diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed an agreement with Portola Pharmaceuticals, Inc. to develop and supply the VerifyNow System and VerifyNowTests for use in clinical trials.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces that patient screening has begun in the second of two Phase 3 clinical trials with the investigational topical drug candidate DSC127 for the treatment of diabetic foot ulcers.
› Verified 9 days ago
Graves Crawley Stubblefield Jr., M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 406 Briarwood Dr, Jackson, MS 39206 Phone: 601-991-1933 Fax: 601-978-3844 | |
Dr. Rebecca Chick Pace, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 N State St, Suite 500, Jackson, MS 39202 Phone: 601-352-2273 Fax: 601-714-3415 | |
Jewelian Akbar Baig, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 971 Lakeland Dr Ste 356, Jackson, MS 39216 Phone: 601-200-4644 Fax: 601-200-4645 | |
Jo P Deal, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 766 Lakeland Dr # A, Jackson, MS 39216 Phone: 601-368-3440 Fax: 601-368-3441 | |
Caryl P. Sumrall, FNP Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 2500 North State Street, Department Of Medicine/division Of General Internal Med, Jackson, MS 39216 Phone: 601-984-5660 | |
Meghan Alford Luter, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5532 | |
Tammy H Young, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1227 N State St, Ste 101, Jackson, MS 39202 Phone: 601-355-2485 Fax: 601-353-1463 |